Nuvation Bio Inc (NYSE: NUVB) on Friday, plunged -3.75% from the previous trading day, before settling in for the closing price of $2.40. Within the past 52 weeks, NUVB’s price has moved between $1.52 and $4.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -504.76%. With a float of $228.71 million, this company’s outstanding shares have now reached $335.25 million.
Let’s determine the extent of company efficiency that accounts for 51 employees. In terms of profitability, gross margin is -32.69%, operating margin of -5541.88%, and the pretax margin is -21940.68%.
Nuvation Bio Inc (NUVB) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Nuvation Bio Inc is 32.13%, while institutional ownership is 43.25%. The most recent insider transaction that took place on Nov 11 ’24, was worth 162,883. In this transaction CEO, ANHEART THERAPEUTICS LTD. of this company sold 56,361 shares at a rate of $2.89, taking the stock ownership to the 3,866,228 shares. Before that another transaction happened on Oct 08 ’24, when Company’s Director bought 100,000 for $2.20, making the entire transaction worth $220,000. This insider now owns 100,000 shares in total.
Nuvation Bio Inc (NUVB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -504.76% per share during the next fiscal year.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Nuvation Bio Inc (NUVB) is currently performing well based on its current performance indicators. A quick ratio of 9.57 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 361.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Looking closely at Nuvation Bio Inc (NYSE: NUVB), its last 5-days average volume was 1.86 million, which is a drop from its year-to-date volume of 2.9 million. As of the previous 9 days, the stock’s Stochastic %D was 5.03%. Additionally, its Average True Range was 0.20.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 21.31%, which indicates a significant increase from 3.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.87% in the past 14 days, which was lower than the 73.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.70, while its 200-day Moving Average is $2.85. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $2.44. Second resistance stands at $2.56. The third major resistance level sits at $2.64. If the price goes on to break the first support level at $2.24, it is likely to go to the next support level at $2.16. Should the price break the second support level, the third support level stands at $2.04.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
Market capitalization of the company is 779.78 million based on 336,567K outstanding shares. Right now, sales total 0 K and income totals -75,800 K. The company made 730 K in profit during its latest quarter, and -41,210 K in sales during its previous quarter.
